LY6E and breast cancer: While most normal tissues have low levels of LY6E expression, common epithelial malignancies, such as breast cancer (64%), pancreatic cancer (63%), non-small-cell lung cancer (56%), and ovarian cancer (53%), commonly have high levels of LY6E expression (IHC 2/3+).